中国慢性HBV感染者基因型分布及其临床意义Meta分析*

doi:10.3969/j.issn.1672-5069.2017.03.005

摘要/Abstract

摘要： 目的探讨中国乙型肝炎病毒（HBV）基因型分布及其临床意义。方法在万方数据库和NCBI数据库检索有关中国HBV基因型分布的研究论文,将中国分为不同HBV感染流行区,分析不同地区、民族和肝脏疾病类型人群HBV基因A、B、C、B/C、D型和其他基因型（非A~D基因型和非B/C混合型）分布。采用Meta分析基因型分布特点及其临床意义。结果在我国,HBV基因型主要以B基因型和C基因型为主,区域1（北部地区）HBV 基因A、B、C、B/C、D型和其他型分别为0.1%、22.2%、69.1%、3.8%、0.5%和1.5%,其中C基因型比例显著高于其它区域（P<0.05）;区域2（中部地区）HBV 基因A、B、C、B/C、D型和其他型分别为0.2%、62.6%、27.4%、3.8%、0.5%和2.4%,其中B基因型比例显著高于其它区域（P<0.05）;区域3（南部地区）HBV 基因A、B、C、B/C、D型和其他型分别为0.6%、36.3%、49.4%、2.8%、2.6%和3.4%,其中C基因型比例显著高于区域2的27.4%（P<0.05）;区域4（青藏高原）感染HBV B基因型、C基因型、D基因型和其他基因型分别为6.0%、22.5%、11.7%和59.3%,其中C/D混合型比例显著高于其他区域（P<0.05）;藏族人群C/D混合型比例（49.3%）显著高于其他民族（P<0.05）,哈萨克族D基因型比例（58.1%）显著高于其他民族（P<0.05）; C基因型与慢性乙型肝炎、HBV相关性肝硬化和肝癌显著相关（OR=1.979、OR=3.888、OR=4.399,P<0.001）。结论不同地区和民族HBV基因型分布显著不同,B基因型可能是中国HBV起源基因,而感染C基因型更有可能引起严重的肝脏疾病。

关键词: 乙型肝炎, 基因型, 民族, 分布

Abstract: Objective To uncover the characteristics of distribution of hepatitis B virus （HBV） genotypes in China. Methods Papers on study of HBV genotypes in China were searched in Wanfang and NCBI databases, and the epidemic zone were classified by different regions,ethnicity,and category of liver diseases. The data of these studies were analyzed by meta-analysis to observe the distribution of genotypes and related clinical significance in each classification. Results In China,the genotypes B and genotype C of hepatitis B virus were the main genotypes;The HBV A,B,C,B/C,D and other genotype infection in patients in area 1 （North area） were 0.1%,22.2%,69.1%,3.8%,0.5% and 1.5%,with genotype C significantly higher than patients in other areas （P<0.05）;The HBV A,B,C,B/C,D and other genotype infection in patients in area 2 （Central area） were 0.2%,62.6%,27.4%,3.8%,0.5% and 2.4%,with genotype B significantly higher than patients in other areas （P<0.05）; In area 3 （South area）,the HBV A,B,C,B/C,D and other genotype infection were 0.6%,36.3%,49.4%,2.8%,2.6% and 3.4%,with genotype C significantly higher than patients in area 2（27.4%,P<0.05）;In area 4 （Qinghai-Tibet plateau）,the HBV B,C,D and other genotype infection were 6.0%,22.5%,11.7%,59.3%,with genotype C/D significantly higher than patients in other areas（all P<0.05）;Additionally,genotype distribution among different nationalities was significantly different. Genotype C/D recombination（49.3%） in Tibetan population was significantly higher than patients in other nationalities （all P<0.05）,and genotype D in Kazak was 58.1%,significantly higher than patients in other nationalities （all P<0.05）;Genotype C was significantly positively correlated with chronic hepatitis B,HBV related liver cirrhosis and hepatocellular carcinoma （Odds ratios:1.979,3.888,4.399,respectively,all P<0.001）. Conclusion The distributions of HBV genotypes in different regions and nationalities are significantly different,and the findings of this study suggests that genotype B might be the original strain of Chinese HBV infection,and genotype C is more likely to cause severe liver damage.

Key words: Hepatitis B, Genotypes, Nationalities, Distribution

伍宵, 魏少峰, 徐楠, 苏倩, 李旭, 张振华. 中国慢性HBV感染者基因型分布及其临床意义Meta分析^*[J]. 实用肝脏病杂志, 2017, 20(3): 271-275.

Wu Xiao, Wei Shaofeng, Xu Nan, et al.. Meta-analysis on distribution of hepatitis B virus genotypes and related clinical outcomes in China[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 271-275.

参考文献

[1] Janus N,Vacher LV,Karie S,et al.Vaccination and chronic kidney disease. Nephrol Dial Transplant,2008,23:800-807.
[2] Lai CL,Ratziu V,Yuen MF,et al.Viral hepatitis B. Lancet,2003,362:2089-2094.
[3] Custer B,Sullivan SD,Hazlet TK,et al.Global epidemiology of hepatitis B virus. J Clin Gastroenterol,2004,38:S158-168.
[4] Liang X,Bi S,Yang W,et al.Reprint of: Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine,2013,31:J21-28.
[5] Okamoto H,Tsuda F,Sakugawa H,et al.Typing hepatitis B virus by homology in nucleotide sequence:comparison of surface antigen subtypes. J Gen Virol,1988,69:2575-2583.
[6] Olinger CM,Jutavijittum P,Hubschen JM,et al.Possible new hepatitis B virus genotype,southeast Asia. Emerg Infect Dis,2008,14:1777-1780.
[7] Shi W,Zhang Z,Ling C,et al.Hepatitis B virus subgenotyping:history,effects of recombination,misclassifications,and corrections. Infect Genet Evol,2013,16:355-361.
[8] Tanaka Y,Hasegawa I,Kato T,et al.A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D. Hepatology,2004,40:747-755.
[9] Devesa M,Loureiro CL,Rivas Y,et al.Subgenotype diversity of hepatitis B virus American genotype F in Amerindians from Venezuela and the general population of Colombia. J Med Virol,2008,80:20-26.
[10] Liu WC,Phiet PH,Chiang TY,et al.Five subgenotypes of hepatitis B virus genotype B with distinct geographic and virological characteristics. Virus Res,2007,129:212-223.
[11] Kato H,Gish RG, Bzowej N,et al.Eight genotypes(A-H) of hepatitis B virus infecting patients from San Francisco and their demographic,clinical,and virological characteristics. J Med Virol,2004,73:516-521.
[12] Chan HL,Wong GL,Tse CH,et al.Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype B. Clin Gastroenterol Hepatol,2009,7:1361-1366.
[13] Lin CL,Kao JH.The clinical implications of hepatitis B virus genotype:Recent advances. J Gastroenterol Hepatol,2011,26:123-130.
[14] 杜晓菲,马丽娜,柳雅之,等. 39例成人急性乙型肝炎患者血清HBV基因变异检测及其临床意义探讨.实用肝脏病杂志,2016,19:524-527.
[15] Chen SM,Kung CM,Yang WJ,et al.Efficacy of the nationwide hepatitis B infant vaccination program in Taiwan.J Clin Virol,2011,52:11-16.
[16] Kwan,Ho YY,Lee SS. The declining HBsAg carriage rate in pregnant women in Hong Kong. Epidemiol Infect,1997,119:281-283.
[17] Mulders MN,Venard V,Njayou M,et al.Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis,2004,190:400-408.
[18] 张振华,张玲,陆蒙古,等. 中国乙型肝炎病毒B、C基因型参照序列的建立. 中华肝脏病杂志,2009,17:891-895.
[19] Zhang Z,Xia J,Sun B, et al.In vitro and in vivo replication of a chemically synthesized consensus genome of hepatitis B virus genotype B. J Virol Methods,2015,213:57-64.
[20] 殷继明,金荣华,严艳,等. 慢性乙型肝炎患者HBV基因型和亚型分布调查. 实用肝脏病杂志,2010,13:19-21.
[21] Sunbul M.Hepatitis B virus genotypes: global distribution and clinical importance. World J Gastroenterol,2014,20:5427-5434.
[22] Louisirirotchanakul S,Olinger CM,Arunkaewchaemsri P,et al.The distribution of hepatitis B virus genotypes in Thailand. J Med Virol,2012,84:1541-1547.
[23] Ismail AM,Puhazhenthi KS,Sivakumar J,et al.Molecular epidemiology and genetic characterization of hepatitis B virus in the Indian subcontinent. Int J Infect Dis,2014:20:1-10.
[24] Saikia A,Bose M,Barman NN,et al.Molecular epidemiology of HBV infection in chronic hepatitis B virus infected patients in northeast India. J Med Virol,2015,87:1539-1548.
[25] Yuen MF, Sablon E,Tanaka Y,et al.Epidemiological study of hepatitis B virus genotypes,core promoter and precore mutations of chronic hepatitis B infection in Hong Kong. J Hepatol,2004,41:119-125.
[26] Zhou B,Xiao L,Wang Z,et al.Geographical and ethnic distribution of the HBV C/D recombinant on the Qinghai-Tibet Plateau PLoS One,2011,6:e18708.
[27] Zhou B,Wang Z,Yang J,et al.Novel evidence of HBV recombination in family cluster infections in western China. PLoS One,2012,7:e38241.
[28] KramvisA,Kew M,Francois G. Hepatitis B virus genotypes. Vaccine,2005,23:2409-2423.
[29] Schaefer S.Hepatitis B virus genotypes in Europe. Hepatol Res,2007,37:S20-26.
[30] Sumi H,Yokosuka O,Seki N,et al.Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology,2003,37:19-26.
[31] Chu CJ,Hussain M,Lok AS.Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology,2002,122:1756-1762.

中国慢性HBV感染者基因型分布及其临床意义Meta分析^*

Meta-analysis on distribution of hepatitis B virus genotypes and related clinical outcomes in China

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	朱凌云, 张茂海, 崔莎莎, 张秋萍. 慢性乙型肝炎患者血清IL-12、IL-18水平和外周血单个核细胞FOXp3基因水平研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 816-819.
[2]	石莹莹, 王元喜. 替比夫定联合阿德福韦酯治疗慢性乙型肝炎患者效果及其对肾功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 820-823.
[3]	闵峰, 黄文琪, 吴卫兵, 张丽, 范荣华. 慢性乙型肝炎患者血清脂肪细胞因子水平变化及其临床意义^*[J]. 实用肝脏病杂志, 2019, 22(6): 824-827.
[4]	张迎明, 申爽, 田飞, 孙园园. IFNL4和IL-28B基因多态性检测评估慢性乙型肝炎患者抗病毒治疗应答价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 828-831.
[5]	吴海义, 陈建新. 四种诊断模型诊断乙型肝炎病毒携带者肝纤维化的效能分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 832-835.
[6]	马丽英, 沈利娟. 妊娠后期应用替诺福韦治疗血清HBV高载量孕妇阻断HBV母婴传播的疗效及安全性分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 836-839.
[7]	李传杰, 徐静, 王亮亮, 潘劲劲, 刘波. 恩替卡韦治疗慢性乙型肝炎患者血清HBsAg变化与病毒学应答的相关性研究[J]. 实用肝脏病杂志, 2019, 22(6): 928-929.
[8]	杜科业, 杨东亮, 刘嘉. 慢性乙型肝炎与调节性T细胞研究进展^*[J]. 实用肝脏病杂志, 2019, 22(5): 613-616.
[9]	廖桂婵, 彭颉, 张小勇. 肝细胞介导的天然免疫应答参与控制乙型肝炎病毒感染^*[J]. 实用肝脏病杂志, 2019, 22(5): 617-619.
[10]	赵协山, 伍春瑢, 王春峰, 余积洁, 何青. 替诺福韦联合安络化纤丸治疗HBeAg阴性慢性乙型肝炎患者疗效及其血清肝纤维化指标的变化研究*[J]. 实用肝脏病杂志, 2019, 22(5): 644-647.
[11]	涂杰霞, 王安娜, 廖若汐. 干扰素α-2b与聚乙二醇干扰素α-2a治疗慢性乙型肝炎患者疗效比较研究*[J]. 实用肝脏病杂志, 2019, 22(5): 648-651.
[12]	高伟, 侯勇. 肝脏硬度值检测诊断慢性乙型肝炎患者肝组织纤维化的效能分析*[J]. 实用肝脏病杂志, 2019, 22(5): 652-655.
[13]	邓浩辉, 李晓强, 高洪波, 陈伟烈. HIV/HCV混合感染者与HCV感染者感染HCV基因型分析*[J]. 实用肝脏病杂志, 2019, 22(5): 656-659.
[14]	朱玉成, 闫家微, 孙景坤, 张秋月. 慢加急性肝衰竭患者血清二胺氧化酶水平及其临床意义探讨*[J]. 实用肝脏病杂志, 2019, 22(5): 672-675.
[15]	张梅, 石秀英, 李林娟, 薛亚妮. 肝源性糖尿病患者肝组织干扰素诱导蛋白-10表达变化*[J]. 实用肝脏病杂志, 2019, 22(5): 688-691.